2023
DOI: 10.3390/ph16060777
|View full text |Cite
|
Sign up to set email alerts
|

Asymmetric Lipid Vesicles: Techniques, Applications, and Future Perspectives as an Innovative Drug Delivery System

Denisse Gardea-Gutiérrez,
Eduardo Núñez-García,
Berenice E. Oseguera-Guerra
et al.

Abstract: Novel lipid-based nanosystems have been of interest in improving conventional drug release methods. Liposomes are the most studied nanostructures, consisting of lipid bilayers ideal for drug delivery, thanks to their resemblance to the cell plasma membrane. Asymmetric liposomes are vesicles with different lipids in their inner and outer layers; because of this, they can be configured to be compatible with the therapeutic drug while achieving biocompatibility and stability. Throughout this review, topics such a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 79 publications
(120 reference statements)
0
2
0
Order By: Relevance
“…Conventional drug delivery systems, such as oral and injectable systems, have certain shortcomings to some extent, such as poor bioavailability and imprecise targeting [89][90][91]. The ideal drug delivery system would have a microporous shape, no influence on the efficacy of the drug itself, few side effects and precisely controlled release [92][93][94].…”
Section: Drug Deliverymentioning
confidence: 99%
“…Conventional drug delivery systems, such as oral and injectable systems, have certain shortcomings to some extent, such as poor bioavailability and imprecise targeting [89][90][91]. The ideal drug delivery system would have a microporous shape, no influence on the efficacy of the drug itself, few side effects and precisely controlled release [92][93][94].…”
Section: Drug Deliverymentioning
confidence: 99%
“…Liposomes are composed of non-toxic phospholipids and cholesterol and have a structure similar to that of a biofilm [ 24 , 25 ]. Therefore, compared to other nanocarriers, they have better biocompatibility and lower toxicity [ 26 , 27 ]. The bilayer structure of the liposomes allows them to simultaneously encapsulate two drugs with different properties: hydrophilic and hydrophobic [ 28 , 29 ].…”
Section: Introductionmentioning
confidence: 99%